26
Participants
Start Date
January 8, 2021
Primary Completion Date
January 19, 2022
Study Completion Date
April 13, 2022
Alisporivir
Administration of alisporivir at the dose of 600 mg p.o. BID from D1 to D14 to patients and standard of care (SOC).
Standard of care (SOC)
Locally accepted regimen protocols for patient care and select agents based on the underlying diagnosis and the severity of COVID 19 (excepting e.g. azithromycin and other antibiotics listed as prohibited medications)
Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil
Collaborators (1)
Debiopharm International SA
INDUSTRY
Assistance Publique - Hôpitaux de Paris
OTHER